PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression Jun 15, 2021
Traction for Psychedelics: First Psychedelics ETF Comes to the US as Bills Move Forward in California, Texas, and New… Jun 9, 2021
What Is A Compassionate Access Trial? Numinus CSO & Co-Founder Stacey Wallin Has The Details Jun 7, 2021
National Institutes of Health Director Praises Psychedelics and Medical Cannabis Research May 31, 2021
PharmaTher Collaborates with MediSynergics to Develop Patented Ketamine Formulation for Pain Disorders and to Discover… May 27, 2021
